Stacey Johnson

For almost 20 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. Prior to that, Stacey was at the CTV Television Network, first as a researcher, then as a story producer for “Goldhawk Fights Back,” a special ombudsman segment that aired weekly on the National News and Canada AM. Before joining CCRM as the Director, Communications and Marketing, Stacey was the Director of Communications for the Canadian Arthritis Network. Stacey is editor of Signals. You can follow Stacey on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn: Visual analytics go viral (KT part 3)

Author: Stacey Johnson, 09/15/17

A fundamental (and obvious) truth about knowledge translation (KT) is that if you want your work to have impact, it needs to be engaging. A viral video reaches thousands or millions of people; a boring, complex, badly produced video reaches a handful of people (your family, closest friends and some colleagues. Maybe a curious ex.)…Read more

Right Turn: Why #ILookLikeAnEngineer is still around

Author: Stacey Johnson, 09/08/17

  I was on a Toronto subway this week and saw a woman wearing a button with #ILookLikeAnEngineer (see image right). Having blogged about this topic myself in 2015 and also having featured the blog of a female engineer sharing her thoughts, I was pleased to see this important campaign had jumped over to the…Read more

Right Turn: Teaching kids critical thinking skills

Author: Stacey Johnson, 09/01/17

I love kids. Their curiosity, passion and enthusiasm for life are infectious. With two teenagers at home, kids and school are very much on my mind right now. (I have a habit of blogging about back-to-school, as you can read here and here.) Because kids are so curious, they constantly explore the world around them….Read more

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Right Turn: ‘Right to try’ state of affairs in U.S.

Author: Stacey Johnson, 08/25/17

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that took on this cause in the first place. Earlier this month, the U.S….Read more

Weighing in on a controversial topic

Author: Stacey Johnson, 08/23/17

We are less than one week away from Signals’ second blog carnival! Last month I promised to reveal the topic and the participants. I also hinted that this year’s topic might strike some readers as controversial. Given that a few invited bloggers declined to participate, I’d have to say that’s the case. So although our…Read more

Right Turn: Vacationing on Mars

Author: Stacey Johnson, 08/18/17

Hi Loyal Readers, Happy summer! Thanks for your visits all year. I’m on vacation this week, but I thought I’d leave you with something anyway. Next week, I’ll provide some more details about the upcoming blog carnival taking place August 29th. I hope you’ll drop by to read all the interesting blogs and different points…Read more

Right Turn: Small device packs big potential

Author: Stacey Johnson, 08/11/17

Whenever something sounds too good to be true, it usually is. The expression is used widely in a variety of contexts, one of which is as a warning to avoid being taken in by a scam or taken advantage of. Unfortunately, it applies to the stem cell field too. I am tempted to state that…Read more

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more